140 141 142 143 144 145 [146] 147 148 149 150 151 152 153 154 155 156 157 158 159 160 
| PRODUCT NAME | CAS Registry Number | ||||||||
| Dapirolizumab pegol (3 suppliers) | 1416147-64-2 | ||||||||
DAPITANT (5 suppliers)
IUPAC Name: (2S)-1-[(3aS,4S,7aS)-4-hydroxy-4-(2-methoxyphenyl)-7,7-diphenyl-1,3,3a,5,6,7a-hexahydroisoindol-2-yl]-2-(2-methoxyphenyl)propan-1-one | CAS Registry Number: 153438-49-4Synonyms: Dapitant, Rpr 100893, Rpr-100893, Rpr 103253, CHEBI:160714, CID132961, 1-[4-Hydroxy-4-(2-methoxy-phenyl)-7,7-diphenyl-octahydro-isoindol-2-yl]-2-(2-methoxy-phenyl)-propan-1-one, 1H-Isoindol-4-ol, octahydro-4-(2-methoxyphenyl)-2-(2-(2-methoxyphenyl)-1-oxopropyl)-7,7-diphenyl-, (3aS-(2(R*),3aalpha,4beta,7aalpha))-
InChIKey: CCIWVEMVBWEMCY-RCFOMQFPSA-N | 153438-49-4 | ||||||||
Dapivirine (12 suppliers)
IUPAC Name: 4-[[4-(2,4,6-trimethylanilino)pyrimidin-2-yl]amino]benzonitrile | CAS Registry Number: 244767-67-7Synonyms: dapivirinum, UNII-TCN4MG2VXS, TMC120, TMC-120, TMC 120, CHEBI:214423, MolPort-000-003-506, AIDS105293, AIDS-105293, TMC120-R147681, CID214347, ZINC00007761, TMC-120/R-147681, TX-010131, R147681, R 147681, R-147681, 4-[4-(2,4,6-TRIMETHYL-PHENYLAMINO)-PYRIMIDIN-2-YLAMINO]-BENZONITRILE, 4-((4-((2,4,6-Trimethylphenyl)amino)pyrimidin-2-yl)amino)benzonitrile, TPB
InChIKey: ILAYIAGXTHKHNT-UHFFFAOYSA-N | 244767-67-7 | ||||||||
| Dapivirine hydrochloride (2 suppliers) | 244768-47-6 | ||||||||
| DAPIVIRINE, [PYRIMIDINE-2-14C]- (0 suppliers) | 2087974-45-4 | ||||||||
| Dapivirine-[d4] (3 suppliers) | 1309283-15-5 | ||||||||
DAPIVIRINE-D11 (5 suppliers)
IUPAC Name: 4-[[4-[3,5-dideuterio-2,4,6-tris(trideuteriomethyl)anilino]pyrimidin-2-yl]amino]benzonitrile | CAS Registry Number: 1329613-10-6Synonyms: Dapivirine-d11, Dapivirine D11, TMC 120-d11, TMC 120R147681-d11, R 147681-d11, 4-[[4-[(2,4,6-Trimethylphenyl-d11)amino]-2-pyrimidinyl]amino]benzonitrile
InChIKey: ILAYIAGXTHKHNT-UXJCIKOESA-N | 1329613-10-6 | ||||||||
DAPK Substrate Peptide (4 suppliers)
IUPAC Name: 2-[[2-[[4-amino-2-[[2-[[2-[[2-[[2-[[5-amino-2-[[1-[2-[[6-amino-2-(2,6-diaminohexanoylamino)hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoyl]amino]-3-methylbutanoyl]amino]-3-phenylpropanoic acid | CAS Registry Number: 386769-53-5
InChIKey: DTEBSHTZDDUPBW-UHFFFAOYSA-N | 386769-53-5 | ||||||||
| DAPK1 (0 suppliers) | 1904-05-30 | ||||||||
| DAPK1 ligand-1 (1 supplier) | 3057532-78-9 | ||||||||
| DAPK1 Protein, Human, Recombinant (aa 1-363, His & GST) (1 supplier) | |||||||||
| DAPK1-IN-1 (2 suppliers) | 1429522-04-2 | ||||||||
DapL-IN-1 (2 suppliers)
IUPAC Name: N-[3-(hydrazinecarbonyl)naphthalen-2-yl]benzenesulfonamide | CAS Registry Number: 423732-11-0Synonyms: dapl-in-1, CHEMBL589313, N-(3-Hydrazinocarbonyl-naphthalen-2-yl)-benzenesulfonamide, N-[3-(hydrazinecarbonyl)naphthalen-2-yl]benzenesulfonamide, CBMicro_037846, MLS000974620, HMS2848I09, ZINC446308, BDBM50481547, SMR000496817, BIM-0037839.P001, AB00101013-01, SR-01000223506, SR-01000223506-1, N-[3-(hydrazinocarbonyl)-2-naphthyl]benzenesulfonamide, 3-(Phenylsulfonylamino)naphthalene-2-carboxylic acid hydrazide
InChIKey: NBSWNEYEAADJGQ-UHFFFAOYSA-N | 423732-11-0 | ||||||||
| Daplusiran (1 supplier) | 2202783-35-3 | ||||||||
| dApNHpp (1 supplier) | 753429-25-3 | ||||||||
| DAPOA (3 suppliers) | 2389064-43-9 | ||||||||
| Dapol EI (1 supplier) | 121266-61-3 | ||||||||
Daporinad (3 suppliers)
IUPAC Name: (E)-N-[4-(1-benzoylpiperidin-4-yl)butyl]-3-pyridin-3-ylprop-2-enamide | CAS Registry Number: 201034-75-5Synonyms: 658084-64-1, FK866, FK-866, APO-866, APO866, APO 866, FK 866, UNII-V71TF6V9M7, Daporinad [INN], (E)-N-(4-(1-BENZOYLPIPERIDIN-4-YL)BUTYL)-3-(PYRIDIN-3-YL)ACRYLAMIDE, V71TF6V9M7, N-(4-(1-benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide, FK 866 hydrochloride, FK866 (APO866), (2E)-N-(4-(1-Benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)prop-2-enamide, (2E)-N-[4-(1-Benzoyl-4-piperidinyl)butyl]-3-(3-pyridinyl)-2-propenamide, (2e)-N-{4-[1-(Benzenecarbonyl)piperidin-4-Yl]butyl}-3-(Pyridin-3-Yl)prop-2-Enamide, 2gvj, Daporinad (FK866, APO866), DGB
InChIKey: KPBNHDGDUADAGP-VAWYXSNFSA-N | 201034-75-5 | ||||||||
| Daporinad hydrochloride (1 supplier) | 2727965-45-7 | ||||||||
Dapoxetine (36 suppliers)
IUPAC Name: (1S)-N,N-dimethyl-3-naphthalen-1-yloxy-1-phenylpropan-1-amine | CAS Registry Number: 119356-77-3Synonyms: Dapoxetine [INN], Dapoxetinum [INN-Latin], Dapoxetina [INN-Spanish], LY210448, LY 210448, LS-30482, Benzenemethanamine, N,N-dimethyl-alpha-(2-(1-naphthalenyloxy)ethyl)-, (+)-, 129938-20-1
InChIKey: USRHYDPUVLEVMC-FQEVSTJZSA-N | 119356-77-3 | ||||||||
| Dapoxetine citric acid (0 suppliers) | 1259938-20-1 | ||||||||
Dapoxetine hydrochloride (42 suppliers)
IUPAC Name: (1S)-N,N-dimethyl-3-naphthalen-1-yloxy-1-phenylpropan-1-amine | CAS Registry Number: 129938-20-1Synonyms: Dapoxetine, Dapoxetine [INN], Dapoxetinum [INN-Latin], Dapoxetina [INN-Spanish], LY210448, LY 210448, LS-30482, Benzenemethanamine, N,N-dimethyl-alpha-(2-(1-naphthalenyloxy)ethyl)-, (+)-, 119356-77-3
InChIKey: USRHYDPUVLEVMC-FQEVSTJZSA-N | 129938-20-1 | ||||||||
| Dapoxetine Impurity 1 (2 suppliers) | 119357-22-1 | ||||||||
| Dapoxetine Impurity 2 (4 suppliers) | 2242008-37-1 | ||||||||
| Dapoxetine Impurity 24 (1 supplier) | 1445281-20-8 | ||||||||
| Dapoxetine Impurity 3 (1 supplier) | 2095189-99-2 | ||||||||
| Dapoxetine Impurity 4 HCl (1 supplier) | 119357-39-0 | ||||||||
Dapoxetine Impurity 42 (1 supplier)
IUPAC Name: naphthalen-1-yl methanesulfonate | CAS Registry Number: 38262-42-9Synonyms: naphthalen-1-yl methanesulfonate, naphthyl mesylate, naphthyl methylsulfonate, 1-(Mesyloxy)naphthalene, naphthalen-1-yl mesylate, SCHEMBL476328, ZINC4659218, AKOS005139440, MCULE-4993520475, ST51067892
InChIKey: XDMSBAHISPQMNW-UHFFFAOYSA-N | 38262-42-9 | ||||||||
| Dapoxetine Impurity 45 (2 suppliers) | 2242008-38-2 | ||||||||
| Dapoxetine Impurity 52 (1 supplier) | 81402-53-1 | ||||||||
| Dapoxetine Impurity 57 (1 supplier) | 1445281-25-3 | ||||||||
| Dapoxetine Impurity 59 (1 supplier) | 2249892-48-4 | ||||||||
| Dapoxetine Impurity 62 (2 suppliers) | 31844-86-7 | ||||||||
| Dapoxetine Impurity 64 (1 supplier) | 1610980-30-7 | ||||||||
| Dapoxetine Impurity 68 (1 supplier) | 119357-48-1 | ||||||||
| Dapoxetine Impurity 71 (1 supplier) | 1621684-78-3 | ||||||||
| Dapoxetine Impurity 72 (1 supplier) | 2249892-52-0 | ||||||||
| Dapoxetine Impurity 73 (Hydrochloride) (1 supplier) | 2415108-76-6 | ||||||||
| Dapoxetine Impurity 8 (2 suppliers) | 2245197-07-1 | ||||||||
| Dapoxetine Impurity 81 (1 supplier) | 2415108-74-4 | ||||||||
| Dapoxetine Impurity 84 (1 supplier) | 149045-41-0 | ||||||||
| Dapoxetine Impurity 85 (1 supplier) | 24241-74-5 | ||||||||
DAPOXETINE N-OXIDE (90%) (4 suppliers)
IUPAC Name: (1S)-N,N-dimethyl-3-naphthalen-1-yloxy-1-phenylpropan-1-amine oxide | CAS Registry Number: 1346603-24-4Synonyms: Dapoxetine N-Oxide, Dapoxetine N-Oxide (90%), ZINC77286396, (|AS)-N,N-Dimethyl-|A-[2-(1-naphthalenyloxy)ethyl]benzenemethanamine N-Oxide, (|AS)-N,N-Dimethyl-N-oxido-|A-[2-(1-naphthalenyloxy)ethyl]benzenemethanamine
InChIKey: LVJBASLGSATTOZ-FQEVSTJZSA-N | 1346603-24-4 | ||||||||
| Dapoxetine-[d6] (3 suppliers) | 1132642-58-0 | ||||||||
Dapoxetine-d6 Hydrochloride (4 suppliers)
IUPAC Name: (1S)-3-naphthalen-1-yloxy-1-phenyl-N,N-bis(trideuteriomethyl)propan-1-amine;hydrochloride | CAS Registry Number: 1246814-76-5Synonyms: [2H6]-(S)-N,N-dimethyl-a-[2-(1-naphthalenyloxy)ethyl]-benzenemethanamine hydrochloride
InChIKey: IHWDIQRWYNMKFM-RURDCJKXSA-N | 1246814-76-5 | ||||||||
| Dapoxetine-d7 HCl (3 suppliers) | 1132642-56-8 | ||||||||
| Dapoxetine-d7 hydrochloride (2 suppliers) | 2699607-47-9 | ||||||||
| DAPP 2,5-Diamino-6-(5-phospho-D-ribitylamino)-pyrimidin-4(3H)-one (1 supplier) | 71491-00-4 | ||||||||
| Dapral GE 202Na (9CI) (0 suppliers) | 124153-24-8 | ||||||||
Daprodustat (3 suppliers)
IUPAC Name: 2-[(1,3-dicyclohexyl-2,4,6-trioxo-1,3-diazinane-5-carbonyl)amino]acetic acid | CAS Registry Number: 960539-70-2Synonyms: UNII-JVR38ZM64B, JVR38ZM64B, GSK-1278863, GTPL8455, GSK1278863, N-((1,3-Dicyclohexylhexahydro-2,4,6-trioxopyrimidin-5-yl)carbonyl)glycine, 2-[(1,3-dicyclohexyl-2,4,6-trioxo-1,3-diazinane-5-carbonyl)amino]acetic acid, Glycine, N-((1,3-dicyclohexylhexahydro-2,4,6-trioxo-5-pyrimidinyl)carbonyl)-
InChIKey: RUEYEZADQJCKGV-UHFFFAOYSA-N | 960539-70-2 |